Autoimmunity, insulin resistance and beta cell function in subjects with low body weight type 2 diabetes mellitus

Metabolic Syndrome and Related Disorders

Volumn 5, Issue 2, 2007, Pages 136-141

  Das, Sidhartha ^a,c   Bhoi, Sanjeev Kumar ^a   Baliarsinha, A K ^a   Baig, Mirza Asraf Ali ^b  

^a Sriram Chandra Bhanj Medical College   (India)

^b ORISSA UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (India)

^c NONE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; IA ANTIBODY; INSULIN;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; BODY MASS; BODY WEIGHT; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INDIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

EID: 34250698943     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2006.0024     Document Type: Article

References (20)

1. Powers AC. Diabetes mellitus. Harrison's Principle of Internal Medicine Vol. II. New York: McGraw-Hill Publishers, 2005:2152-2180.
2. Mohan V, Alberti KGMM. Diabetes in the tropics. International Text Book of Diabetes Mellitus. Chichester: Wiley 1991:177-196.
3. Ramachandran A, Jali MV, Mohan V, Snehalatha C, Viswanathan M. High prevalence of diabetes in an urban population in South India. BMJ 1988;297:587-590.
4. Das S. Low body weight Type 2 DM. J Nutr Env Med 1999;9:229-239
5. Das, S., Samal, K.C., Baliarsinha, A.K. Lean (under weight) NIDDM - Pecularities and differences in metabolic and hormonal status. J Assn Phys Ind 1995;43:339-342
6. Mohan V, Vijayaprabha R, Rema M, Premlatha G, Poongothai S, Deepa Bhatia E, Mackay IR, Zimmet P. Clinical profile of lean NIDDM in South India. Diabetes Res Clin Prac 1997;38:101-108.
7. International Workshop on Types of Diabetes Peculiar to the Tropics. Malnutritional diabetes in the tropics. Diabetes Care 1996;19:1014-1017.
8. Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, Lang A. Latant autoimmune diabetes mellitus in adults (LADA): The role of anti-bodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diab Med 1994;11:299-303.
9. Unnikrishnan AG, Singh SK, Sanjeevi CB. Prevalence of GAD65 antibodies in lean subjects with Type 2 diabetes. Ann NY Acad Sci 2004;1037:118-121.
10. Das S, Tripathy BB, Samal KC, Panda NC. Plasma lipids and lipoprotein cholesterol in undernourished diabetic subjects and adults with protein energy malnutrition. Diabetes Care 1984;7:579-586.
11. Das S, Reynolds T, Patnaik A, Rais N, Fink LM, Fonseca VA. Plasma homocysteine concentrations in Type 2 diabetic patients in India: Relationship to body mass index. J Diab Comp 1999;13:200-203.
12. Das S, ed. Low Bodyweight Type 2 Diabetes Mellitus. Technical series. Mumbai: Indian College of Physicians, Academic Wing of Association of Physicians of India. (ISBN 81-900354-4-4) 1999:1-95.
13. Das S, Misra RK, Samal KC, Mishra KC, Tripathy BB. Insulin and glycemic response to common carbohydrate diets in undernourished diabetics. J Nutr Med 1991;2:351-358.
14. Alberti KGMM, Zimmet P. Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: Diagnosis and classification of diabetes mellitus. Provisional report of WHO consultation. Diab Med. 1998;15:539-553.
15. Mattews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
16. Group LC, Bottazzo GF, Doniach D. Islet cell antibodies identify latent type 1 diabetes in patients aged 35-75 yrs in diagnosis. Diabetes 1986;35:237-241.
17. Gottaster A, Landin-Olsson M, Ferlund P, Lenmark A, Sundkvist G. Beta cell function in relation to islet cell antibodies during the first 3 years after clinical diagnosis of diabetes in type II diabetic patients. Diabetes 1993;42:352-362.
18. Niskanen LK, Tumoi T, Karjalainan J, Groop LC, Uusitupa MI. GAD antibodies in NIDDM. Diabetes Care 1995;18:1557-1565.
19. Tuomi T, Carlsson A, Haiyan L, Isomaa B, Miettinen A, Nilsson A, Nissén M, Ehrnström B-O, Forsėn B, Snickars B, Lathi K, Forsblom C, Saloranta C, Taskinen M-R, and Leif C. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 1999;48:150-157.
20. Fukui M, Nakano K, Maruya E, Diagnostic significance of antibodies to glutamic acid decarboxylase in Japanese diabetic patients with secondary oral hypoglycemic agent failure. Clin Immunol Immunopathol 1997;85:182-186.